Curegene Stock

Curegene focuses on the treatment of anti-viral diseases as well as cardiovascular and cerebrovascular diseases.

Sign up today and learn more about Curegene Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Curegene Stock

Curegene focuses on the treatment of anti-viral diseases as well as cardiovascular and cerebrovascular diseases. The company has made strides in the development of small molecules and nucleic acid pharmaceuticals and currently possesses the most advanced targeted prodrug and nucleic acid drug technology platforms.

Funding History

January 2024$100M

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo